Author: OurCrowd

[Highcon in PR Newswire] Highcon secures equity investment, strategic partnership with BHS and PO’s for 2 Beam 2Cs

YAVNE, Israel , Oct. 23, 2023 /PRNewswire/ — Highcon Systems Ltd (TASE: HICN), today announced a commitment by existing and new investors to make a new equity investment in the Company, a restructuring of its bank loans and credit lines and the receipt of orders for two units of the Highcon Beam 2C worth $~4M. Building on these important achievements, the Company has built a new business plan to reach positive cash flow and toward operational profitability in 2024. In addition, Highcon is announcing the installation of two units of the Beam 2 digital die cutting system in Europe for folding carton and together with BHS Corrugated Maschinen (BHS) today jointly announced a Strategic Partnership expected to have far-reaching implications for the digitalization of the corrugated packaging market. Read...

Read More

[DreaMed in DreaMed] DreaMed receives 5th FDA Clearance

TEL AVIV, Israel: DreaMed Diabetes LTD. (“DreaMed” or the “Company”), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes patients who use insulin pumps or injections and monitor their glucose using continuous glucose monitor and/or blood glucose meters. Read...

Read More